her2+ breast cancer may be less common than previously quoted
I previously quoted a study from the Hawaii tumor registry with 11% her 2 positivity, here is a study from Sweden looking into whether their her2 testing is reproducible across the country showing a 14% incidence.
In the review article I posted on 10 years of targetted her2 therapy, they noted that it will probably turn out that her2+ breast cancer is quite a bit less
prevalent than previously quoted ie, 20-25%.
|